RAC 2.20% $1.78 race oncology ltd

Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett, page-62

  1. 122 Posts.
    lightbulb Created with Sketch. 35
    The issue isn the drug, the science, the valuations, or our happy calculators.

    The issue is our execution. So far it has been a shit show.

    We can have the best drug in the world, but if we can't get the board singing off the same song sheet and steering this ship in the right direction nothing else matters.


    DT Buying is positive, it is not the be all and end all how ever.

    I am hopeful however the board can sort its differences out and get us back on track.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.